Mindray Medical International has received the US Food and Drug Administration (FDA) 510(k) clearance for its A5 Anesthesia System.
The A5 anesthesia delivery platform, part of the all new A Series portfolio, will complement Mindray‘s broad range of existing ultrasound and patient monitoring systems.
The A5’s intuitive user interface and ergonomic design simplify workflows and its 15" touch screen enables clinicians to quickly and easily select ventilation settings.
The A5 provides a range of advanced ventilation modes enabling effective care across different patient acuity types and integrated spirometry offers additional information which enhances careful decision making.
The auxiliary O2/Air Blender reduces the risk of surgical fires by controlling the oxygen concentration under the drape, near the patient’s head and chest.
Mindray North America president David Gibson said the A5 is the first of their new series of anesthesia machines that bring advanced design features to the Mindray portfolio.
"By creating a highly differentiated product that includes more standard ventilation features, we are expanding our ability to serve the US hospital market," Gibson said.